Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | AR | P10275 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | HPGD | P15428 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TNF | P01375 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13658697 | 0.98 | RAB9A (0.42) | CYP3A4CYP1A2RAB9ANPC1AR | |
| SCHEMBL13658693 | 0.92 | CYP1A2 (0.45) | CYP3A4CYP1A2RAB9ANPC1AR | |
| SCHEMBL13682528 | 0.92 | ALDH1A1 (0.44) | CYP3A4CYP1A2RAB9ANPC1AR | |
| SCHEMBL17427669 | 0.90 | TNF (0.44) | CYP3A4CYP1A2RAB9ANPC1AR | |
| SCHEMBL30527261 | 0.90 | TNF (0.44) | CYP3A4CYP1A2RAB9ANPC1AR | |
| SCHEMBL19768384 | 0.86 | CYP3A4 (0.41) | CYP3A4CYP1A2RAB9ANPC1AR | |
| SCHEMBL13682534 | 0.84 | PIK3CA (0.47) | CYP3A4CYP1A2ALDH1A1HPGDMAPT | |
| SCHEMBL13658709 | 0.84 | CYP1A2 (0.42) | CYP3A4CYP1A2RAB9ANPC1AR | |
| SCHEMBL16484896 | 0.83 | SMN1; SMN2 (0.43) | CYP3A4CYP1A2RAB9ANPC1AR | |
| SCHEMBL13682484 | 0.83 | PIK3CA (0.46) | CYP3A4CYP1A2CYP2C9ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9887365-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-02-06 | — | — | US | disclosed |
| US-9887365-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-02-06 | — | — | US | disclosed |
| US-20160141513-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-05-19 | — | — | US | disclosed |
| US-20160141513-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-05-19 | — | — | US | disclosed |
| US-9296695-B2 | Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-03-29 | — | — | US | disclosed |
| US-9296695-B2 | Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-03-29 | — | — | US | disclosed |
| EP-2110373-B1 | Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same | SAMSUNG DISPLAY CO LTD (KR) | 2012-11-21 | — | — | EP | disclosed |
| EP-2110373-A1 | Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same | Samsung Mobile Display Co., Ltd. (KR) | 2009-10-21 | — | — | EP | disclosed |
| US-20090256473-A1 | BIPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DIODE EMPLOYING ORGANIC LAYER COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-10-15 | — | — | US | disclosed |
| US-20090256473-A1 | BIPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DIODE EMPLOYING ORGANIC LAYER COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090256473-A1 | BIPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DIODE EMPLOYING ORGANIC LAYER COMPRISING THE SAME | OCIAD2, OCIAD1, DRD2 | CYP3A4 162/4885CYP1A2 294/4885RAB9A 1437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.